Junshi Bio (HKEX: 1877, SSE: 688180) Announces Share Reduction Results of Major Shareholder

Bulletin Express12-04

Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding reduction plan within the authorized timeframe from 5 September 2025 to 4 December 2025. According to the official announcement, Shanghai Tanying sold 12,000,000 A shares via block trading, representing approximately 1.1688% of the total share capital.

Following the transaction, Shanghai Tanying now holds 59,459,326 A shares, which constitutes about 5.7914% of the total share capital. This shareholding reduction was prompted by fund maturity and liquidity arrangements, and aligned with disclosures previously made in August 2025. The plan’s execution has concluded, and no further reductions are indicated.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment